Intrinsiqq
The Cigna Group logo

The Cigna Group Quality Score

CI

⊜ Compare
Quality43

Business quality is the primary weakness (avg 45/100). Growth is the relative bright spot.

Broad-market heuristics · Not a buy/sell signal

Valuation and growth

Earnings Multiple
90/100
12.5x

Under 20x, reasonable relative to earnings

Revenue Growth
100/100
11.8%

Above 10% CAGR, strong compounder

Business Quality & Capital Allocation

Share Dilution
100/100
-15.7%

Shrinking >2%, active buybacks

Margin Trend
20/100
-1.2pp

Modest contraction, within normal range

Capital Structure
0/100
$25.62B

Positive debt with no FCF to service it

2022
$6.83B
$31.6B
2023
$8.75B
$32.7B
2024
$8.21B
$32.9B
2025
$8.73B
$31.6B
TTM
$7.26B
$32.9B
CashDebt
Return on Capital
60/100
11.2%

10–15%, respectable returns

Customize WeightsPremiumUpgrade

Cigna (CI) quality: score, margins and returns

Cigna (CI) scores 43/100 on Intrinsiqq's quality score (a mixed business), a weighted blend of 6 metrics each scored 0 to 100, on 3.5% operating margins and 11.2% ROIC. Every metric is computed from SEC filings; this is analysis, not investment advice.

Frequently asked

Is Cigna (CI) a high-quality business?+

Cigna scores 43 out of 100 on Intrinsiqq's quality score, a weighted blend of 6 metrics each scored 0 to 100, which rates it a mixed business on these measures. Recent figures include a 3.5% operating margin and a 11.2% return on invested capital. Quality and price are separate questions: even a great business can be a poor investment if you overpay, so read this score alongside the valuation. The metric-by-metric breakdown is on this scorecard.

What does Cigna's quality score measure?+

Intrinsiqq's quality score weighs revenue and free-cash-flow growth, operating margins, return on invested capital, change in share count, and balance-sheet strength, each computed from CI's SEC filings rather than opinion or sentiment. A higher score means a more durable, capital-efficient business; it is not a buy or sell signal. Open each metric on this page to see exactly where Cigna scores well and where it falls behind.

What is Cigna's return on invested capital (ROIC)?+

Cigna earns about 11.2% on its invested capital, which is solid. ROIC measures how much profit a company generates per dollar put to work; sustained ROIC above its cost of capital is one of the clearest signs of a real competitive moat. Compare it to CI's margins and growth on this scorecard to judge durability.

How profitable is Cigna?+

Cigna runs an operating margin of about 3.5% and a net margin of about 2.3%. Revenue has grown at roughly 11.4% a year recently. High, stable margins usually point to pricing power and operating discipline. Margins are most telling next to growth and returns on capital, all of which feed this quality score. This is analysis from SEC filings, not investment advice.

How the market compares: US profitability statistics

SourceQuality score computed from the 10-Q filed 24 Jul 2026, covering the period ending 30 Jun 2026, as reported to the SEC. Data last refreshed 3 Aug 2026. How this is calculated.

Fiscal year ends Dec. Sector medians are approximate S&P 500 benchmarks and update periodically. Checks use broad-market heuristics, so sector norms may differ, and the valuation checks are more cyclical than the quality checks.

Peers

Hospital & Medical Service Plans · Pick stocks to compare with CI

CompareIntrinsic value
CNCCentene Corporation
$76.01+12.64%55
ELVElevance Health, Inc.
$434.18+4.94%53
HUMHumana Inc.
$417.45-0.10%45
UNHUnitedHealth Group Incorporated
$409.38+1.22%48
MOHMolina Healthcare Inc.
$226.49+8.97%37
BRK-ABerkshire Hathaway Inc
$869,301.00+3.93%69
PGRProgressive Corporation
$234.82+2.49%91
METMetLife Inc.
$102.89+2.21%65

Held by ETFs

CI is in 331 US ETFs. The largest of them, with CI's weight in each:

Spot a number that looks wrong? Check it in CI's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing CI

Create a free account and get 14 days of Premium: every stock and every tool.

  • Unlimited stocks
  • Stock screener
  • Portfolio tracker
  • Editable DCF
  • Compare side by side
  • Unlimited alerts

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

SectorsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.